Findings of the new Lockton 2026 National Benefits Survey indicate that 46% of self-funded plan sponsors say they would consider international drug sourcing for pharmacy benefits, an approach that remains complex and may expose plan sponsors to legal and compliance risks if not properly designed and administered.

The key in 2026 is to take a strategic, data-driven approach to employee benefits, designing programs that are both affordable and personalized to support employees and also attracting and retaining talent.

In a letter to staff, CEO Evan Spiegal said rapid AI advances have enabled Snap teams to "reduce repetitive work, increase velocity and better support our community, partners and advertisers."